IPO registrations (S-1, F-1) · Registrants
GenEmbryomics Ltd
- SEC CIK
- 2038033 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2025-02-20, last 2025-03-25; 1 initial registration, 2 amendments
- Outcome
- Declared effective 2025-03-28; withdrawal requested 2025-04-23
- Industry (SIC)
- Services-Medical Laboratories 8071
- Business address
- LEVEL 14, AUSTRALIA SQUARE, 264-278 GEORGE STREET, Sydney, C3 NSW 2000
- EDGAR entity type
- other
Offering terms
- Shares offered
- 1,095,000
- Listing
- Nasdaq under the symbol XGEN
- Lead underwriters
- WallachBeth Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2025-02-20 | F-1 | F-1 (foreign registration) | GenEmbryomics Ltd | 0001437749-25-004473 ↗ |
| 2025-03-17 | F-1/A | F-1/A (amendment) | GenEmbryomics Ltd | 0001437749-25-007827 ↗ |
| 2025-03-25 | F-1/A | F-1/A (amendment) | GenEmbryomics Ltd | 0001437749-25-009095 ↗ |
| 2025-03-28 | EFFECT | EFFECT (declared effective) | GenEmbryomics Ltd | 9999999995-25-000837 ↗ |
| 2025-04-23 | RW | RW (withdrawal request) | GenEmbryomics Ltd | 0001437749-25-012742 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | F-1/A | registration statement | $4.75 | 1,095,000 | $5,201,250 | Nasdaq XGEN | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Services-Medical Laboratories, C3 first:
- Centogene N.V. 2M
- Med BioGene Inc. A1
- DYNACARE INC A6
- MDxHealth SA C9
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- GENOMIC HEALTH INC CA
- PERLEGEN SCIENCES, INC. CA
In other datasets, the same topic (Health) in C3:
- Form D issuer: Botanix Pharmaceuticals Ltd. (Form D private offerings)
Interests: Services-Medical Laboratories · Health